AMYLIN PHARMA (AMLN)

Overview Data Buy Sell Hold P&P Help

Brokerage Analyst Zacks All Star Rating Date Recommendation Target Price Additional analysis and Buy / Sell / Hold recommendations have been made by DEUTSCHE BK SEC, BAS - ML and MORGAN STANLEY. If you are a client or partner of one of these firms, you can gain access by registering for access or logging in   Register for Access User Analysis Rating AMYLIN PHARMA a SELL  The analysts believe that the Byetta/LAR safety concerns and pending competition are likely to weigh on the shares. Last edited Fri May 14, 2010 03:10 AM by SudiptaMukherjee (Zacks Investment Research)

---

Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 06:15:37 CDT by WikiMigrationBot.